Knock-down of BMAL1 can significantly reduce the growth of tumors both in vitro and in vivo. In GBM, BMAL1 has been shown to gain thousands of new binding sites compared to normal neural stem cells and is rewired to support tumor specific metabolism of both glucose and fatty acids (13). This evidence concerns the gene BMAL1 and glioblastoma.